Published by Abigail Townsend on 27th September 2022
(Sharecast News) - AstraZeneca drug Tezspire has been approved for use with patients with severe asthma in Japan, the blue chip confirmed on Tuesday.
URL: http://www.digitallook.com/dl/news/story/32989706/...